Brain implants are being trialled for their potential to ameliorate treatment-resistant conditions or to restore function. However, there are no clear guidelines for continued access to brain implants for trial participants whose symptoms improve with these devices.
The views expressed are those of the authors alone, and do not necessarily reflect views of the NIH or Baylor College of Medicine.
CIOMS/WHO guidelines: https://cioms.ch/wp-content/uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf
Belmont Report: https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/
The Dish: Participants as Partners: https://allofus.nih.gov/news-events-and-media/videos/dish-participants-partners
The authors thank M. Husain and A. Viswanathan for helpful input about issues addressed in this article. Research for this article was funded by the US National Institute of Mental Health (grant R01-MH114854-01 to G.L.M.), the US National Eye Institute (grant R01-EY023336-04 to D.Y.) and the US National Institute of Neurological Disorders and Stroke (grant UH3-NS100549-01 to W.K.G.).